RxDoctor Payments Data

Lorelei Sunderland

Family · Tonganoxie, KSNPI 1174613103

Payments from drug & device makers

$841in general payments, 2019–2025

Across 46 payments — averaging $18.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$267
  • Novo Nordisk$177
  • Amgen$71
  • Otsuka America Pharmaceutical, Inc.$68
  • AstraZeneca$49
  • Johnson & Johnson$32
  • plus $177 from 9 others

What the payments were for

  • Food & beverage$841100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$841 in reported general payments places this provider in the 70th percentile of 1,579 family providers in Kansas.

See all family providers in Kansas

Medicare billing

Part B allowed, 2024
$26,048
Medicare patients
105
Services billed
706

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide42$45,222
OzempicSemaglutide28$34,619
XareltoRivaroxaban17$11,450
EliquisApixaban12$7,420
MyrbetriqMirabegron16$7,114
Humalog Kwikpen U-100Insulin Lispro12$1,928
SynthroidLevothyroxine Sodium12$1,133
Gabapentin70$1,014
Omeprazole58$857
Albuterol Sulfate HfaAlbuterol Sulfate35$841
Levothyroxine Sodium102$788
Atorvastatin Calcium120$599
Omega-3 Acid Ethyl Esters12$549
Losartan Potassium49$384
Fluticasone Propionate42$359

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$267$45,22242 claims
Novo NordiskOzempic$177$34,61928 claims
Johnson & JohnsonXarelto$32$11,45017 claims
AbbVieSynthroid$18$1,13312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,579 family providers in Kansas.

Other family in Tonganoxie

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →